Property generally : externalities, coordination, and the public domain
Intellectual property: the public domain and private rights
Taming conflict of interests
Federally sponsored research under Bayh-Dole
The single monopoly : current patent limitations
Rate regulation : an unneeded swamp
Patent purchases: a second swamp
Socialization of R & D : the final swamp
The steady expansion of FDA power
FDA versus the individual : upstream or downstream decision making
Drug withdrawal : too much, too soon
Getting the drugs to market
Product liability for prescription drugs : manufacturing and design cases
The main event : misrepresentation, overpromotion, and duty to warn
Conclusion : socialized medicines.
